Home | All trials

[RDF data]
Trial NCT00000337

Resource URI: http://static.linkedct.org/resource/trials/NCT00000337
PropertyValue
linkedct:brief_title Infusion Laboratory: Protocol 1 - Selegeline - 2
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Inclusion Criteria: M/F, ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
linkedct:description To develop a medication for the treatment of cocaine addiction using a medical human physio-neuro-psycho-immunology laboratory setting. To characterize this cocaine abusing population on a variety of psychological and physicologically measures over time from withdrawal through pere and post cocaine administration. To determine the effects of selegeline on the subjective and physiological effects of cocaine challenge in chronic crack abusers. To evaluate clinical safety issues pertaining to selegeline, to cocaine and their interaction in a chronic crack dependent population.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 47 Years
linkedct:eligibility_minimum_age 31 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000337
rdfs:label Trial NCT00000337
linkedct:lastchanged_date November 3, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/209856>
linkedct:nct_id NCT00000337
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Infusion Laboratory: Protocol 1 - Selegeline
linkedct:org_study_id NIDA-3-0010-2
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/60742>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000337>
linkedct:phase Phase 1
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/10066>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/16400>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/25534>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4409>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4701>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/6361>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/6374>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/8467>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/8471>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/9137>
linkedct:secondary_id Y01-3-0010-2
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date November 1994
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to determine the effects of selegiline on the subjective and physiological effects of cocaine challenge in chronic crack abusers, and to evaluate clinical safety issues pertaining to selegeline, to cocaine and their interaction in a chronic crack dependent population.
rdf:type linkedct:trials
linkedct:verification_date August 1996